Average Co-Inventor Count = 4.56
ph-index = 25
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Schering Corporation (104 from 1,829 patents)
2. Dendreon Corporation (5 from 53 patents)
3. Other (1 from 832,680 patents)
4. Schering-plough Animal Health Corporation (1 from 30 patents)
106 patents:
1. RE43298 - Peptides as NS3-serine protease inhibitors of hepatitis C virus
2. 7759349 - Control of parasites in animals by the use of imidazo[1,2-b]pyridazine derivatives
3. 7595299 - Peptides as NS3-serine protease inhibitors of hepatitis C virus
4. 7244721 - Peptides as NS3-serine protease inhibitors of hepatitis C virus
5. 7169760 - Peptides as NS3-serine protease inhibitors of hepatitis C virus
6. 7115578 - Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
7. 7012066 - Peptides as NS3-serine protease inhibitors of hepatitis C virus
8. 6924270 - Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
9. 6914122 - Macrocyclic NS-3 serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties
10. 6846802 - Macrocyclic NS3-serine protease inhibitors of hepatitis C virus comprising N-cyclic P2 moieties
11. 6838475 - Imidazolidinones as NS3-serine protease inhibitors of hepatitis C virus
12. 6800434 - Peptides as NS3-serine protease inhibitors of hepatitis C virus
13. 6673775 - Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection
14. 6432959 - Inhibitors of farnesyl-protein transferase
15. 6403564 - Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection